Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Enterprise Value (2016 - 2026)

Healthequity has reported Enterprise Value over the past 14 years, most recently at -$318.9 million for Q1 2026.

  • For Q1 2026, Enterprise Value fell 7.76% year-over-year to -$318.9 million; the TTM value through Jan 2026 reached -$318.9 million, down 7.76%, while the annual FY2026 figure was -$318.9 million, 7.76% down from the prior year.
  • Enterprise Value for Q1 2026 was -$318.9 million at Healthequity, down from -$309.3 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$161.2 million in Q2 2022 and troughed at -$404.0 million in Q1 2024.
  • A 5-year average of -$276.4 million and a median of -$290.3 million in 2023 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: soared 78.11% in 2022 and later crashed 64.14% in 2023.
  • Year by year, Enterprise Value stood at -$210.2 million in 2022, then plummeted by 58.93% to -$334.1 million in 2023, then rose by 3.56% to -$322.2 million in 2024, then rose by 4.01% to -$309.3 million in 2025, then fell by 3.13% to -$318.9 million in 2026.
  • Business Quant data shows Enterprise Value for HQY at -$318.9 million in Q1 2026, -$309.3 million in Q4 2025, and -$304.5 million in Q3 2025.